Learn / ABCL
NASDAQ: ABCL
AbCellera Biologics (ABCL) stock, explained like you're 5
AbCellera Biologics trades on the Nasdaq under the ticker ABCL. It is a mid cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 4.1 billion dollars.
- Ticker
- ABCL
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Size
- Mid cap, about 4.1 billion dollars
Is AbCellera Biologics a small, medium or large cap company?
No. AbCellera Biologics is a mid cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 4.1 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How AbCellera Biologics makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves ABCL stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Why Did SLS, MRNA, ABCL Stocks Surge To 52 Week Highs Last Week? (Stocktwits)
- ABCL Stock Surges 121% in 3 Months: Here's What You Need to Know (Yahoo Finance)
- AbCellera Biologics (NasdaqGS:ABCL) Stock Forecast & Analyst Predictions (Simply Wall Street)
- AbCellera Biologics (ABCL) Institutional Ownership 2026 (MarketBeat)
- AbCellera Biologics Stock (ABCL) Opinions on Recent Surge and Insider Buying (Quiver Quantitative)
Follow ABCL in your daily brief
Each trading day at 5 PM ET we post what happened to AbCellera Biologics and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow ABCL
Questions about AbCellera Biologics stock
What does AbCellera Biologics do?
AbCellera Biologics trades on the Nasdaq under the ticker ABCL. It is a mid cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 4.1 billion dollars.
What is the ticker symbol for AbCellera Biologics?
AbCellera Biologics trades under the ticker ABCL on the Nasdaq.
What is AbCellera Biologics's market cap?
AbCellera Biologics is a mid cap stock with a market cap of about 4.1 billion dollars.
How does AbCellera Biologics make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves ABCL stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow ABCL stock every day?
Add ABCL to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.